SMITH JASON DREW (General Counsel) sold 17.6% of their position (4.99K shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $78.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Ordinary Shares
Shares
+834.00
Price / share
—
Trade value
—
% of position
Ordinary Shares
Shares
−417.00
Price / share
$15.74
Trade value
$6.56K
% of position
Ordinary Shares
Shares
+2.50K
Price / share
—
Trade value
—
% of position
Ordinary Shares
Shares
−1.25K
Price / share
$15.74
Trade value
$19.64K
% of position
Ordinary Shares
Shares
+6.67K
Price / share
—
Trade value
—
% of position
Ordinary Shares
Shares
−3.33K
Price / share
$15.74
Trade value
$52.38K
% of position
Net shares
+5.01K
Net value
-$78.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 1/31/2024 | M · Option Exercise | +834.00 | — | — | 4.5% | 18.41K | 19.24K |
| Ordinary Shares Direct | 1/31/2024 | S · Sale | −417.00 | $15.74 | $6.56K | 2.2% | 19.24K | 18.82K |
| Ordinary Shares Direct | 1/31/2024 | M · Option Exercise | +2.50K | — | — | 13.3% | 18.82K | 21.32K |
| Ordinary Shares Direct | 1/31/2024 | S · Sale | −1.25K | $15.74 | $19.64K | 5.9% | 21.32K | 20.08K |
| Ordinary Shares Direct | 1/31/2024 | M · Option Exercise | +6.67K | — | — | 33.2% | 20.08K | 26.74K |
| Ordinary Shares Direct | 1/31/2024 | S · Sale | −3.33K | $15.74 | $52.38K | 12.4% | 26.74K | 23.41K |
| Total | +5.01K | -$78.59K | ||||||
Restricted Stock Units
Ordinary Shares
834.00 shares
Shares
−834.00
Strike price
Held after
0.00
Exercisable
—
Restricted Stock Units
Ordinary Shares
2.50K shares
Shares
−2.50K
Strike price
Held after
2.50K
Exercisable
—
Restricted Stock Units
Ordinary Shares
6.67K shares
Shares
−6.67K
Strike price
Held after
13.33K
Exercisable
—
Restricted Stock Units
Ordinary Shares
16.50K shares
Shares
+16.50K
Strike price
Held after
16.50K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares834.00 shares | 1/31/2024 | M · Option Exercise | −834.00 | — | 0.00 | |
| Restricted Stock Units Direct | Ordinary Shares2.50K shares | 1/31/2024 | M · Option Exercise | −2.50K | — | 2.50K | |
| Restricted Stock Units Direct | Ordinary Shares6.67K shares | 1/31/2024 | M · Option Exercise | −6.67K | — | 13.33K | |
| Restricted Stock Units Direct | Ordinary Shares16.50K shares | 1/31/2024 | A · Award | +16.50K | — | 16.50K |